Search results
Results: 94
Number of items: 94
-
Den Toom, I. J., Bloemena, E., van Weert, S., Karagozoglu, K. H., Hoekstra, O. S., & de Bree, R. (2017). Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes. European Archives of Oto-Rhino-Laryngology, 274(2), 961-968. https://doi.org/10.1007/s00405-016-4280-2 -
den Toom, I. J., van Schie, A., van Weert, S., Karagozoglu, K. H., Bloemena, E., Hoekstra, O. S., & de Bree, R. (2017). The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer. European Journal of Nuclear Medicine and Molecular Imaging, 44(6), 998-1004. https://doi.org/10.1007/s00259-017-3613-8 -
Mes, S. W., te Beest, D., Poli, T., Rossi, S., Scheckenbach, K., van Wieringen, W. N., Brink, A., Bertani, N., Lanfranco, D., Silini, E. M., van Diest, P. J., Bloemena, E., Leemans, C. R., van de Wiel, M. A., & Brakenhoff, R. H. (2017). Prognostic modeling of oral cancer by gene profiles and clinicopathological co-variables. Oncotarget, 8(35), 59312-59323. https://doi.org/10.18632/oncotarget.19576 -
Bloemena, E. (2017). De onbekende dokter. Hoofd-Hals magazine, 6, 20-22. https://www.yumpu.com/nl/document/fullscreen/60017394/pvhh-magazine-augustus-2016 -
Tartaglione, G., Stoeckli, S. J., de Bree, R., Schilling, C., Flach, G. B., Bakholdt, V., Sorensen, J. A., Bilde, A., von Buchwald, C., Lawson, G., Dequanter, D., Villareal, P. M., Forcelledo, M. F. F., Amézaga, J. A., Moreira, A., Poli, T., Grandi, C., Vigli, M. G., O'Doherty, M., ... McGurk, M. (2016). Sentinel node in oral cancer: the nuclear medicine aspects. a survey from the sentinel European node trial. Clinical nuclear medicine, 41(7), 534-542. https://doi.org/10.1097/RLU.0000000000001241
-
Schouten, C. S., Hakim, S., Boellaard, R., Bloemena, E., Doornaert, P. A., Witte, B. I., Braakhuis, B. J. M., Brakenhoff, R. H., Leemans, C. R., Hoekstra, O. S., & de Bree, R. (2016). Interaction of quantitative 18F-FDG-PET-CT imaging parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma. Head & Neck, 38(4), 529-535. https://doi.org/10.1002/hed.23920
-
Kuiper, J. L., Hashemi, S. M. S., Thunnissen, E., Snijders, P. J. F., Grünberg, K., Bloemena, E., Sie, D., Postmus, P. E., Heideman, D. A. M., & Smit, E. F. (2016). Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment. The British journal of cancer, 115(12), 1504-1512. https://doi.org/10.1038/bjc.2016.372 -
Punt, S., Dronkers, E. A. C., Welters, M. J. P., Goedemans, R., Koljenovic, S., Bloemena, E., Snijders, P. J. F., Gorter, A., van der Burg, S. H., Baatenburg de Jong, R. J., & Jordanova, E. S. (2016). A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency. Cancer immunology and immunotherapy, 65(4), 393-403. https://doi.org/10.1007/s00262-016-1805-x -
Schilling, C., Stoeckli, S. J., Haerle, S. K., Broglie, M. A., Huber, G. F., Sorensen, J. A., Bakholdt, V., Kroghdal, A., von Buchwald, C., Bilde, A., Sebbesen, L. R., Odell, E., Gurney, B., O'Doherty, M., de Bree, R., Bloemena, E., Flach, G. B., Villareal, P. M., Fresno Forcelledo, M. F., ... McGurk, M. (2015). Sentinel European Node Trial (SENT): 3-year results of sentinel node biopsy in oral cancer. European Journal of Cancer, 51(18), 2777-2784. https://doi.org/10.1016/j.ejca.2015.08.023
Page 3 of 10